| SpectraBase Spectrum ID |
JIlXmwAbXyy |
| Name |
Metodesnitazene |
| Classification |
Nitazene opioid designer drug |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| DEA Citation |
21 CFR §1308.11 (h) (53) |
| DEA Controlled Substance Name |
Metodesnitazene |
| DEA Controlled Substance Type |
Isomers, esters, ethers, salts and salts of isomers, esters and et |
| DEA Controlled Substances Code Number |
9764 |
| DEA Schedule |
Schedule I |
| DEA Section |
Temporary listing of substances subject to emergency scheduling. Any material, compound, mixture or preparation which contains any quantity of the following substances. |
| Exact Mass |
337.215412500 u |
| Formula |
C21H27N3O |
| InChI |
InChI=1S/C21H27N3O/c1-4-23(5-2)14-15-24-20-9-7-6-8-19(20)22-21(24)16-17-10-12-18(25-3)13-11-17/h6-13H,4-5,14-16H2,1-3H3 |
| InChIKey |
SFNKTTXBZXVGOH-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
337.467 g/mol |
| Nominal Mass |
337 u |
| Quality |
985 |
| Retention Index |
2749 |
| SMILES |
C=12N(C(=NC2=CC=CC1)CC1=CC=C(C=C1)OC)CCN(CC)CC |
| SPLASH |
splash10-000i-9100000000-4dcc20cb176029486575 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
BRN 0765000
NSC 659139
N,N-Diethyl-2-(2-(4-methoxybenzyl)-1H-benzo[d]imidazol-1-yl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_031476 |
